Tryptophan degradation and immune activation in Alzheimer's disease |
| |
| Authors: | B. Widner F. Leblhuber J. Walli G. P. Tilz U. Demel D. Fuchs |
| |
| Affiliation: | (1) Institute of Medical Chemistry and Biochemistry, University of Innsbruck,, AT;(2) Department of Gerontology, Neurological Clinic Wagner-Jauregg, Linz, and, AT;(3) Department of Internal Medicine, University of Graz, Austria, AT |
| |
| Abstract: | Summary. Alzheimer's disease (AD) is likely associated with systemic immune activation. During immune response, interferon-gamma stimu-lates indoleamine 2,3-dioxygenase (IDO) converting tryptophan to N-formylkynurenine followed by kynurenine in an ensuing step. Thus, IDO activity is estimated by the kynurenine per tryptophan quotient (Kyn/Trp). In 21 patients suffering from AD, in 20 controls of similar age, and in 49 blood donors we measured serum tryptophan and kynurenine concentrations by HPLC. Lower tryptophan concentrations were found in elderly control subjects compared to blood donors (62.1 vs. 73.0 μM, p < 0.005). Tryptophan concentrations tended to be still lower in AD patients (54.4 μM, p = 0.07) compared to elderly controls. Enhanced tryptophan degradation in patients was reflected by significantly increased Kyn/Trp (46.1 vs. 34.1 in elderly controls, p < 0.05). Correlations were found in patients between Kyn/Trp and concentrations of soluble immune markers in serum, i.e., neopterin, interleukin-2 receptor and tumor necrosis factor receptor (all p < 0.001). Increased Kyn/Trp was associated with reduced cognitive performance. Tryptophan degradation due to immune activation may exert impact on the pathogenesis of AD. Received May 15, 1999; accepted August 24, 1999 |
| |
| Keywords: | : Alzheimer's disease tryptophan kynurenine kynurenine per tryptophan quotient immune activation soluble immune markers neopterin. |
| 本文献已被 PubMed SpringerLink 等数据库收录！ |
|
